|
1
|
Degenhardt K, Mathew R, Beaudoin B, et al:
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 10:51–64. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kroemer G, Marino G and Levine B:
Autophagy and the integrated stress response. Mol Cell. 40:280–293.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rosenfeldt MT and Ryan KM: The multiple
roles of autophagy in cancer. Carcinogenesis. 32:955–963. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mizushima N: Autophagy: process and
function. Genes Dev. 21:2861–2873. 2007. View Article : Google Scholar
|
|
5
|
Yue Z: Regulation of neuronal autophagy in
axon: implication of autophagy in axonal function and
dysfunction/degeneration. Autophagy. 3:139–141. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Scharl M and Rogler G: Inflammatory bowel
disease: dysfunction of autophagy? Dig Dis. 30(Suppl 3): 12–19.
2012. View Article : Google Scholar
|
|
7
|
Yamaguchi O and Otsu K: Role of autophagy
in aging. J Cardiovasc Pharmacol. 60:242–247. 2012. View Article : Google Scholar
|
|
8
|
Eskelinen EL: The dual role of autophagy
in cancer. Curr Opin Pharmacol. 11:294–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liang C and Jung JU: Autophagy genes as
tumor suppressors. Curr Opin Cell Biol. 22:226–233. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang JD and Roberts LR: Hepatocellular
carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 7:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fares N and Peron JM: Epidemiology,
natural history, and risk factors of hepatocellular carcinoma. Rev
Prat. 63:216–217. 2013.(In French).
|
|
12
|
Guerrieri F, Belloni L, Pediconi N, et al:
Molecular mechanisms of HBV-associated hepatocarcinogenesis. Semin
Liver Dis. 33:147–156. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamazaki K, Masugi Y and Sakamoto M:
Molecular pathogenesis of hepatocellular carcinoma: altering
transforming growth factor-beta signaling in hepatocarcinogenesis.
Dig Dis. 29:284–288. 2011. View Article : Google Scholar
|
|
14
|
Maillard E: Epidemiology, natural history
and pathogenesis of hepatocellular carcinoma. Cancer Radiother.
15:3–6. 2011.(In French).
|
|
15
|
Ni HM, Williams JA, Yang H, et al:
Targeting autophagy for the treatment of liver diseases. Pharmacol
Res. 66:463–474. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cui J, Gong Z and Shen HM: The role of
autophagy in liver cancer: molecular mechanisms and potential
therapeutic targets. Biochim Biophys Acta. 1836:15–26.
2013.PubMed/NCBI
|
|
17
|
Rautou PE, Mansouri A, Lebrec D, et al:
Autophagy in liver diseases. J Hepatol. 53:1123–1134. 2010.
View Article : Google Scholar
|
|
18
|
Cabibbo G, Maida M, Genco C, et al:
Natural history of untreatable hepatocellular carcinoma: a
retrospective cohort study. World J Hepatol. 4:256–261. 2012.
View Article : Google Scholar
|
|
19
|
Singh R, Kaushik S, Wang Y, et al:
Autophagy regulates lipid metabolism. Nature. 458:1131–1135. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dolganiuc A, Thomes PG, Ding WX, et al:
Autophagy in alcohol-induced liver diseases. Alcohol Clin Exp Res.
36:1301–1308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ding WX, Li M and Yin XM: Selective taste
of ethanol-induced autophagy for mitochondria and lipid droplets.
Autophagy. 7:248–249. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lavanchy D: Hepatitis B virus
epidemiology, disease burden, treatment, and current and emerging
prevention and control measures. J Viral Hepat. 11:97–107. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Beasley RP: Hepatitis B virus. The major
etiology of hepatocellular carcinoma. Cancer. 61:1942–1956. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sir D, Tian Y, Chen WL, et al: The early
autophagic pathway is activated by hepatitis B virus and required
for viral DNA replication. Proc Natl Acad Sci USA. 107:4383–4388.
2010. View Article : Google Scholar
|
|
25
|
Tian Y, Sir D, Kuo CF, et al: Autophagy
required for hepatitis B virus replication in transgenic mice. J
Virol. 85:13453–13456. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tang H, Da L, Mao Y, et al: Hepatitis B
virus X protein sensitizes cells to starvation-induced autophagy
via up-regulation of beclin 1 expression. Hepatology. 49:60–71.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shinohara Y, Imajo K, Yoneda M, et al:
Unfolded protein response pathways regulate Hepatitis C virus
replication via modulation of autophagy. Biochem Biophys Res
Commun. 432:326–332. 2013. View Article : Google Scholar
|
|
28
|
Sir D, Kuo CF, Tian Y, et al: Replication
of hepatitis C virus RNA on autophagosomal membranes. J Biol Chem.
287:18036–18043. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shrivastava S, Bhanja Chowdhury J, Steele
R, et al: Hepatitis C virus upregulates Beclin1 for induction of
autophagy and activates mTOR signaling. J Virol. 86:8705–8712.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dreux M, Gastaminza P, Wieland SF and
Chisari FV: The autophagy machinery is required to initiate
hepatitis C virus replication. Proc Natl Acad Sci USA.
106:14046–14051. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thoen LF, Guimaraes EL, Dolle L, et al: A
role for autophagy during hepatic stellate cell activation. J
Hepatol. 55:1353–1360. 2011. View Article : Google Scholar
|
|
32
|
Fang H, Liu A, Dahmen U and Dirsch O: Dual
role of chloroquine in liver ischemia reperfusion injury: reduction
of liver damage in early phase, but aggravation in late phase. Cell
Death Dis. 4:e6942013. View Article : Google Scholar
|
|
33
|
Yang JD, Seol SY, Leem SH, et al: Genes
associated with recurrence of hepatocellular carcinoma: integrated
analysis by gene expression and methylation profiling. J Korean Med
Sci. 26:1428–1438. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim JH, Kim HY, Lee YK, et al: Involvement
of mitophagy in oncogenic K-Ras-induced transformation: overcoming
a cellular energy deficit from glucose deficiency. Autophagy.
7:1187–1198. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rosenfeldt MT and Ryan KM: The role of
autophagy in tumour development and cancer therapy. Expert Rev Mol
Med. 11:e362009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qu X, Yu J, Bhagat G, et al: Promotion of
tumorigenesis by heterozygous disruption of the beclin 1 autophagy
gene. J Clin Invest. 112:1809–1820. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kotsafti A, Farinati F, Cardin R, et al:
Autophagy and apoptosis-related genes in chronic liver disease and
hepatocellular carcinoma. BMC Gastroenterol. 12:1182012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Takamura A, Komatsu M, Hara T, et al:
Autophagy-deficient mice develop multiple liver tumors. Genes Dev.
25:795–800. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Guo XL, Li D, Hu F, et al: Targeting
autophagy potentiates chemotherapy-induced apoptosis and
proliferation inhibition in hepatocarcinoma cells. Cancer Lett.
320:171–179. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Uhm JE, Park JO, Lee J, et al: A phase II
study of oxaliplatin in combination with doxorubicin as first-line
systemic chemotherapy in patients with inoperable hepatocellular
carcinoma. Cancer Chemother Pharmacol. 63:929–935. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ding ZB, Hui B, Shi YH, et al: Autophagy
activation in hepatocellular carcinoma contributes to the tolerance
of oxaliplatin via reactive oxygen species modulation. Clin Cancer
Res. 17:6229–6238. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Manov I, Pollak Y, Broneshter R and Iancu
TC: Inhibition of doxorubicin-induced autophagy in hepatocellular
carcinoma Hep3B cells by sorafenib - the role of extracellular
signal-regulated kinase counteraction. FEBS J. 278:3494–3507. 2011.
View Article : Google Scholar
|
|
43
|
Huynh H, Nguyen TT, Chow KH, et al:
Over-expression of the mitogen-activated protein kinase (MAPK)
kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor
progression and apoptosis. BMC Gastroenterol. 3:192003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wilhelm S, Carter C, Lynch M, et al:
Discovery and development of sorafenib: a multikinase inhibitor for
treating cancer. Nat Rev Drug Discov. 5:835–844. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang X, Yang XR, Huang XW, et al:
Sorafenib in treatment of patients with advanced hepatocellular
carcinoma: a systematic review. Hepatobiliary Pancreat Dis Int.
11:458–466. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xie B, Wang DH and Spechler SJ: Sorafenib
for treatment of hepatocellular carcinoma: a systematic review. Dig
Dis Sci. 57:1122–1129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Shimizu S, Takehara T, Hikita H, et al:
Inhibition of autophagy potentiates the antitumor effect of the
multikinase inhibitor sorafenib in hepatocellular carcinoma. Int J
Cancer. 131:548–557. 2012. View Article : Google Scholar
|
|
48
|
Shi YH, Ding ZB, Zhou J, et al: Targeting
autophagy enhances sorafenib lethality for hepatocellular carcinoma
via ER stress-related apoptosis. Autophagy. 7:1159–1172. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hayashi-Nishino M, Fujita N, Noda T, et
al: A subdomain of the endoplasmic reticulum forms a cradle for
autophagosome formation. Nat Cell Biol. 11:1433–1437. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hui B, Shi YH, Ding ZB, et al: Proteasome
inhibitor interacts synergistically with autophagy inhibitor to
suppress proliferation and induce apoptosis in hepatocellular
carcinoma. Cancer. 118:5560–5571. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yu HC, Hou DR, Liu CY, et al: Cancerous
inhibitor of protein phosphatase 2A mediates bortezomib-induced
autophagy in hepatocellular carcinoma independent of proteasome.
PLoS One. 8:e557052013. View Article : Google Scholar
|
|
52
|
Guo XL, Li D, Sun K, et al: Inhibition of
autophagy enhances anticancer effects of bevacizumab in
hepatocarcinoma. J Mol Med (Berl). 91:473–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tai WT, Shiau CW, Chen HL, et al:
Mcl-1-dependent activation of Beclin 1 mediates autophagic cell
death induced by sorafenib and SC-59 in hepatocellular carcinoma
cells. Cell Death Dis. 4:e4852013. View Article : Google Scholar
|
|
54
|
Gao M, Yeh PY, Lu YS, et al: OSU-03012, a
novel celecoxib derivative, induces reactive oxygen species-related
autophagy in hepatocellular carcinoma. Cancer Res. 68:9348–9357.
2008. View Article : Google Scholar
|
|
55
|
Yu HC, Lin CS, Tai WT, et al: Nilotinib
induces autophagy in hepatocellular carcinoma through AMPK
activation. J Biol Chem. 288:18249–18259. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Soliman H, Ringash J, Jiang H, et al:
Phase II trial of palliative radiotherapy for hepatocellular
carcinoma and liver metastases. J Clin Oncol. 31:3980–3986. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Anbalagan S, Pires IM, Blick C, et al:
Radiosensitization of renal cell carcinoma in vitro through the
induction of autophagy. Radiother Oncol. 103:388–393. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Cerniglia GJ, Karar J, Tyagi S, et al:
Inhibition of autophagy as a strategy to augment radiosensitization
by the dual phosphatidylinositol 3-kinase/mammalian target of
rapamycin inhibitor NVP-BEZ235. Mol Pharmacol. 82:1230–1240. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Bristol ML, Di X, Beckman MJ, et al: Dual
functions of autophagy in the response of breast tumor cells to
radiation: cytoprotective autophagy with radiation alone and
cytotoxic autophagy in radiosensitization by vitamin D 3.
Autophagy. 8:739–753. 2012. View Article : Google Scholar
|
|
60
|
Wilson EN, Bristol ML, Di X, et al: A
switch between cytoprotective and cytotoxic autophagy in the
radiosensitization of breast tumor cells by chloroquine and vitamin
D. Horm Cancer. 2:272–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Altmeyer A, Jung AC, Ignat M, et al:
Pharmacological enhancement of autophagy induced in a
hepatocellular carcinoma cell line by high-LET radiation.
Anticancer Res. 30:303–310. 2010.PubMed/NCBI
|
|
62
|
Altmeyer A, Ignat M, Denis JM, et al: Cell
death after high-LET irradiation in orthotopic human hepatocellular
carcinoma in vivo. In Vivo. 25:1–9. 2011.
|
|
63
|
Gao L, Song JR, Zhang JW, et al:
Chloroquine promotes the anticancer effect of TACE in a rabbit VX2
liver tumor model. Int J Biol Sci. 9:322–330. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Ochsner M: Photophysical and
photobiological processes in the photodynamic therapy of tumours. J
Photochem Photobiol B. 39:1–18. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Andrzejak M, Price M and Kessel DH:
Apoptotic and autophagic responses to photodynamic therapy in 1c1c7
murine hepatoma cells. Autophagy. 7:979–984. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Arum CJ, Anderssen E, Viset T, et al:
Cancer immunoediting from immunosurveillance to tumor escape in
microvillus-formed niche: a study of syngeneic orthotopic rat
bladder cancer model in comparison with human bladder cancer.
Neoplasia. 12:434–442. 2010.
|
|
67
|
Liang X, De Vera ME, Buchser WJ, et al:
Inhibiting systemic autophagy during interleukin 2 immunotherapy
promotes long-term tumor regression. Cancer Res. 72:2791–2801.
2012. View Article : Google Scholar
|
|
68
|
Li P, Du Q, Cao Z, et al: Interferon-gamma
induces autophagy with growth inhibition and cell death in human
hepatocellular carcinoma (HCC) cells through interferon-regulatory
factor-1 (IRF-1). Cancer Lett. 314:213–222. 2012. View Article : Google Scholar
|
|
69
|
Su S, Zhou H, Xue M, et al: Anti-tumor
efficacy of a hepatocellular carcinoma vaccine based on dendritic
cells combined with tumor-derived autophagosomes in murine models.
Asian Pac J Cancer Prev. 14:3109–3116. 2013. View Article : Google Scholar
|
|
70
|
Leithead JA, Armstrong MJ, Corbett C, et
al: Hepatic ischemia reperfusion injury is associated with acute
kidney injury following donation after brain death liver
transplantation. Transpl Int. 26:1116–1125. 2013. View Article : Google Scholar
|
|
71
|
Yasuda H, Leelahavanichkul A, Tsunoda S,
et al: Chloroquine and inhibition of Toll-like receptor 9 protect
from sepsis-induced acute kidney injury. Am J Physiol Renal
Physiol. 294:F1050–F1058. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Hoshino A, Matoba S, Iwai-Kanai E, et al:
p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage
after ischemia. J Mol Cell Cardiol. 52:175–184. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Gotoh K, Lu Z, Morita M, et al:
Participation of autophagy in the initiation of graft dysfunction
after rat liver transplantation. Autophagy. 5:351–360. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Degli Esposti D, Sebagh M, Pham P, et al:
Ischemic preconditioning induces autophagy and limits necrosis in
human recipients of fatty liver grafts, decreasing the incidence of
rejection episodes. Cell Death Dis. 2:e1112011.
|
|
75
|
Toso C, Merani S, Bigam DL, et al:
Sirolimus-based immunosuppression is associated with increased
survival after liver transplantation for hepatocellular carcinoma.
Hepatology. 51:1237–1243. 2010. View Article : Google Scholar
|
|
76
|
Yang ZJ, Chee CE, Huang S and Sinicrope
FA: The role of autophagy in cancer: therapeutic implications. Mol
Cancer Ther. 10:1533–1541. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Toshima T, Shirabe K, Matsumoto Y, et al:
Autophagy enhances hepatocellular carcinoma progression by
activation of mitochondrial beta-oxidation. J Gastroenterol. May
24–2013.(Epub ahead of print).
|
|
78
|
Gozuacik D and Kimchi A: Autophagy as a
cell death and tumor suppressor mechanism. Oncogene. 23:2891–2906.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kanzawa T, Kondo Y, Ito H, et al:
Induction of autophagic cell death in malignant glioma cells by
arsenic trioxide. Cancer Res. 63:2103–2108. 2003.
|
|
80
|
Kim EH, Sohn S, Kwon HJ, et al: Sodium
selenite induces superoxide-mediated mitochondrial damage and
subsequent autophagic cell death in malignant glioma cells. Cancer
Res. 67:6314–6324. 2007. View Article : Google Scholar
|
|
81
|
Dupere-Richer D, Kinal M, Menasche V, et
al: Vorinostat-induced autophagy switches from a death-promoting to
a cytoprotective signal to drive acquired resistance. Cell Death
Dis. 4:e4862013. View Article : Google Scholar
|
|
82
|
Takahashi A, Kimura T, Takabatake Y, et
al: Autophagy guards against cisplatin-induced acute kidney injury.
Am J Pathol. 180:517–525. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Ching JK and Weihl CC: Rapamycin-induced
autophagy aggravates pathology and weakness in a mouse model of
VCP-associated myopathy. Autophagy. 9:799–800. 2013. View Article : Google Scholar
|
